Evidence map›Paper›PMID 39605326›Full record

ArticlebioRxiv : the preprint server for biology2024

In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants.

Emily E Bendall, Derek Dimcheff, Leigh Papalambros, William J Fitzsimmons, Yuwei Zhu, Jonathan Schmitz, Natasha Halasa, James Chappell, Emily T Martin, Jessica E Biddle and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Emily E BendallDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, USA.
Derek DimcheffDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Leigh PapalambrosDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
William J FitzsimmonsDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Yuwei ZhuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Jonathan SchmitzDepartment of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.
Natasha HalasaDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
James ChappellDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Emily T MartinDepartment of Epidemiology, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-5771-8895
Jessica E BiddleCenters for Disease Control and Prevention, Atlanta, GA, USA.
Sarah E Smith-JeffcoatCenters for Disease Control and Prevention, Atlanta, GA, USA.
Melissa A RolfesCenters for Disease Control and Prevention, Atlanta, GA, USA.
Alexandra MellisCenters for Disease Control and Prevention, Atlanta, GA, USA.
H Keipp TalbotDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA.
Carlos GrijalvaDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Adam S LauringDepartment of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, USA.

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HENSLEY, SCOTT · 2021 to 2025
$50.7M
Evolution and Transmission of Influenza Virus in Natural Human InfectionR01AI148371 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAURING, ADAM, MARTIN, EMILY TOTH · 2020 to 2024
$3.6M
Mentoring in transmission of influenza and strategies for preventionK24AI148459 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRIJALVA, CARLOS G · 2020 to 2024
$893k
NIAID NIH HHS 75N93021C00015NIAID NIH HHS K24 AI148459NIAID NIH HHS R01 AI148371
6 · The paper itself

Abstract

SARS-CoV-2 has undergone repeated and rapid evolution to circumvent host immunity. However, outside of prolonged infections in immunocompromised hosts, within-host positive selection has rarely been detected. The low diversity within-hosts and strong genetic linkage among genomic sites make accurately detecting positive selection difficult. Longitudinal sampling is a powerful method for detecting selection that has seldom been used for SARS-CoV-2. Here we combine longitudinal sampling with replicate sequencing to increase the accuracy of and lower the threshold for variant calling. We sequenced 577 specimens from 105 individuals from a household cohort primarily during the BA.1/BA.2 variant period. There was extremely low diversity and a low rate of divergence. Specimens had 0-12 intrahost single nucleotide variants (iSNV) at >0.5% frequency, and the majority of the iSNV were at frequencies <2%. Within-host dynamics were dominated by genetic drift and purifying selection. Positive selection was rare but highly concentrated in spike. Two individuals with BA.1 infections had S:371F, a lineage defining substitution for BA.2. A Wright Fisher Approximate Bayesian Computational model identified positive selection at 14 loci with 7 in spike, including S:448 and S:339. We also detected significant genetic hitchhiking between synonymous changes and nonsynonymous iSNV under selection. The detectable immune-mediated selection may be caused by the relatively narrow antibody repertoire in individuals during the early Omicron phase of the SARS-CoV-2 pandemic. As both the virus and population immunity evolve, understanding the corresponding shifts in SARS-CoV-2 within-host dynamics will be important.

Identifiers

PMID39605326
PMCPMC11601520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.